Evidence map›Paper›PMID 29377070›Full record

ReviewCA: a cancer journal for clinicians2018

Factors influencing risk-based care of the childhood cancer survivor in the 21st century.

Stephanie B Dixon, Kari L Bjornard, Nicole M Alberts, Gregory T Armstrong, Tara M Brinkman, Wassim Chemaitilly, Matthew J Ehrhardt, Israel Fernandez-Pineda, Lisa M Force, Todd M Gibson and 13 more

Abstract readReview
In one paragraph

Review in CA: a cancer journal for clinicians, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Late effects of the treatment of childhood cancer.World journal of clinical cases · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Stephanie B DixonClinical Hematology/Oncology Fellow, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0003-3901-3274
Kari L BjornardClinical Hematology/Oncology Fellow, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-2881-0027
Nicole M AlbertsResearch Associate, Department of Psychology, St. Jude Children's Research Hospital, Memphis, TN.
Gregory T ArmstrongMember, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
Tara M BrinkmanAssistant Member, Department of Psychology and Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-4250-6160
Wassim ChemaitillyAssociate Member, Department of Pediatric Medicine-Division of Endocrinology and Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
Matthew J EhrhardtAssistant Member, Department of Oncology and Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
Israel Fernandez-PinedaAssistant Member, Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN.
Lisa M ForceClinical Hematology/Oncology Fellow, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
Todd M GibsonAssistant Member, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
Daniel M GreenMember, Department of Oncology and Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
Carrie R HowellClinical Research Scientist, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
Sue C KasteMember, Department of Oncology and Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN; Professor of Radiology, Department of Radiology, University of Tennessee Health Science Center, Memphis, TN.
Anne C KirchhoffAssistant Professor, Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
James L KloskyAssociate Member, Department of Psychology, St. Jude Children's Research Hospital, Memphis, TN.
Kevin R KrullMember, Department of Psychology and Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
John T LucasAssistant Member, Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, TN.
Daniel A MulrooneyAssociate Member, Department of Oncology and Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
Kirsten K NessMember, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
Carmen L WilsonAssistant Member, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
Yutaka YasuiMember, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
Leslie L RobisonMember, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.
Melissa M HudsonMember, Department of Oncology and Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN.

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
NCI NIH HHS P30 CA021765
6 · The paper itself

Abstract

The population of adult survivors of childhood cancer continues to grow as survival rates improve. Although it is well established that these survivors experience various complications and comorbidities related to their malignancy and treatment, this risk is modified by many factors that are not directly linked to their cancer history. Research evaluating the influence of patient-specific demographic and genetic factors, premorbid and comorbid conditions, health behaviors, and aging has identified additional risk factors that influence cancer treatment-related toxicity and possible targets for intervention in this population. Furthermore, although current long-term follow-up guidelines comprehensively address specific therapy-related risks and provide screening recommendations, the risk profile of the population continues to evolve with ongoing modification of treatment strategies and the emergence of novel therapeutics. To address the multifactorial modifiers of cancer treatment-related health risk and evolving treatment approaches, a patient-centered and risk-adapted approach to care that often requires a multidisciplinary team approach, including medical and behavioral providers, is necessary for this population. CA Cancer J Clin 2018;68:133-152. © 2018 American Cancer Society.

Indexed as

Cancer SurvivorsPatient-Centered CareAdultAge FactorsChildHealth BehaviorHealth Services AccessibilityHumansNeoplasmsQuality of LifeRisk Factorsadolescentantineoplastic agentscancerchilddelivery of health careneoplasmsrisksurvivorstreatment outcome

Identifiers

PMID29377070
PMCPMC8893118

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.